These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6704629)

  • 1. Cavernosal alpha-blockade: a warning.
    Flind AC
    Br J Psychiatry; 1984 Mar; 144():329-30. PubMed ID: 6704629
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection.
    Brindley GS
    Br J Psychiatry; 1986 Aug; 149():210-5. PubMed ID: 3640652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phenoxybenzamine on penile tumescence in diabetic men.
    Brooks ME; Berezin M; Braf ZF
    Urol Res; 1982; 10(5):249-51. PubMed ID: 7164221
    [No Abstract]   [Full Text] [Related]  

  • 4. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence.
    Brindley GS
    Br J Psychiatry; 1983 Oct; 143():332-7. PubMed ID: 6626852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence by GS Brindley.
    Glina S; Shindel A; Eardley I; Ghanem H
    J Sex Med; 2008 Aug; 5(8):1791-4. PubMed ID: 18774989
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-blockade and impotence.
    Riley AJ; Riley EJ
    Br J Psychiatry; 1984 Feb; 144():215-6. PubMed ID: 6704615
    [No Abstract]   [Full Text] [Related]  

  • 8. Cavernosal alpha blockade: a treatment for erectile impotence.
    Cameron L; Woodruff P
    Br J Psychiatry; 1986 Jan; 148():107. PubMed ID: 3955314
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with buccal phentolamine mesylate for impotence.
    Zorgniotti AW
    Int J Impot Res; 1994 Mar; 6(1):37-41. PubMed ID: 7517275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α
    Martínez-Salamanca JI; La Fuente JM; Martínez-Salamanca E; Fernández A; Pepe-Cardoso AJ; Louro N; Carballido J; Angulo J
    J Sex Med; 2016 Dec; 13(12):1844-1857. PubMed ID: 27864032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of inhibition of the angiotensin-converting enzyme (ACE) on cavernosal perfusion in men with atherosclerotic erectile dysfunction: a pilot study.
    Speel TG; Kiemeney LA; Thien T; Smits P; Meuleman EJ
    J Sex Med; 2005 Mar; 2(2):207-12. PubMed ID: 16422888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernous injection of papaverine, phentolamine and phenoxybenzamine.
    Pettirossi O; Serenelli G
    Acta Urol Belg; 1988; 56(2):211-9. PubMed ID: 3400527
    [No Abstract]   [Full Text] [Related]  

  • 13. P144, A TGF-β1 antagonist peptide, synergizes with sildenafil and enhances erectile response via amelioration of cavernosal fibrosis in diabetic rats.
    Li WJ; Wang H; Zhou J; Li B; Zhang J; Lu M; Wang Z
    J Sex Med; 2013 Dec; 10(12):2942-51. PubMed ID: 24134744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue.
    Oger S; Behr-Roussel D; Gorny D; Lecoz O; Lebret T; Denoux Y; Faix A; Leriche A; Wayman C; Alexandre L; Giuliano F
    J Sex Med; 2009 Mar; 6(3):836-47. PubMed ID: 19143907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler Characteristics of Cavernosal-Spongiosal Communications in Patients with Erectile Dysfunction.
    Shen Q; Li J; Zheng D; Lv L; Yang G; He Q
    Ultrasound Med Biol; 2016 Jan; 42(1):159-66. PubMed ID: 26493238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced impotence.
    Mills LC
    Am Fam Physician; 1975 Aug; 12(2):104-6. PubMed ID: 238379
    [No Abstract]   [Full Text] [Related]  

  • 17. [Low-dose tadalafil improves arterial erectile dysfunction].
    Xu ZP; Chen Y; Sun C; Dai YT
    Zhonghua Nan Ke Xue; 2009 Nov; 15(11):1014-6. PubMed ID: 20218314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated intracorporeal self-injection: effect on peak systolic velocity and cavernosal artery diameter.
    Awad H; El-Karaksy A; Mostafa T; Abbas M; Kamel II; Arafa M; Zeidan A
    Int J Impot Res; 2007; 19(5):505-8. PubMed ID: 17581595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intracavernosal growth differentiation factor-5 therapy in a rat model of cavernosal nerve injury.
    Fandel TM; Bella AJ; Tantiwongse K; Garcia M; Nunes L; Thüroff JW; Tanagho EA; Pohl J; Lue TF
    BJU Int; 2006 Sep; 98(3):632-6. PubMed ID: 16796696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Strategy With Oral Phosphodiesterase Type 5 Inhibition and Intracavernosal Implantation of Mesenchymal Stem Cells Is Superior to Individual Approaches in the Recovery of Erectile and Cavernosal Functions After Cavernous Nerve Injury in Rats.
    Martínez-Salamanca JI; Zurita M; Costa C; Martínez-Salamanca E; Fernández A; Castela A; Vaquero J; Carballido J; Angulo J
    J Sex Med; 2016 Jan; 13(1):1-11. PubMed ID: 26755080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.